- Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study. Smith, M.R., Malkowicz, S.B., Chu, F., Forrest, J., Price, D., Sieber, P., Barnette, K.G., Rodriguez, D., Steiner, M.S. J. Urol. (2008)